Recent publicity about a gene mutation found in a family with a hereditary form of Parkinson's disease led families of Parkinson's patients to worry about genetic transmission of the disease to offspring and siblings. A new study puts the discovery in perspective.
Taking vitamin B2 every day can help prevent migraines, according to a report in the February issue of Neurology, the scientific journal of the American Academy of Neurology.
Narcolepsy is more common in people over 40 than previously thought by physicians and the general public, according to a study published in the February issue of Neurology, the American Academy of Neurology's scientific journal.
Hospital physical rehabilitation programs have a positive effect on multiple sclerosis patients that lasts after they return home, according to two new studies published in the current issue of Neurology.
One of the most debilitating effects of Alzheimer's disease is a tendency to become lost in familiar surroundings. A new study suggests that people with Alzheimer's become lost not because they are confused, but because their vision is impaired.
News Briefs from Neurology 1) New Treatment Developed for Parkinson's Disease 2) Study Shows New Treatment for Menstrual Migraine 3) Persian Gulf War Symptoms Not Related to Exposure to Toxins
Media representatives are invited to attend the American Academy of Neurology's 49th Annual Meeting April 12-19 in Boston, MA. Studies presented at the meeting include: 1) Extensive Decongestant Use Linked to Stroke; 2) Gene Affects Risk of Alzheimer's Disease Differently Among Races Please note individual embargo dates.
News Briefs from the American Academy of Neurology Meeting April 12-19: 1) Thrombolytic Therapy Brings Brain-Dead Patient Back to Life; 2) Sleep Disorder in Parkinson's Disease Patients Can Lead to Nocturnal Injury Please note individual embargo dates.
News from AAN Annual Meeting April 12-19: 1) Drug Improves Productivity by 50 Percent for Migraine Sufferers. Embargoed until April 15, 1996; 2) For Immediate Release: AAN Participates in Second Annual Brain Awareness Week, March 17-23
Briefs from March Neurology: 1) Out of the Clear Blue Sky: Rugby Spectator Struck by Lightning 2) Treatment Shows Small Benefit for Some Inclusion-Body Myositis Patients
Studies to be Presented at the American Academy of Neurology Annual Meeting: 1) Gene Therapy in Monkeys May Lead to Treatment for Alzheimer's Disease 2) Stroke Patients Improve Walking Ability with New Therapy
Neurology News Briefs: 1) Proper Management of Sports-Related Concussion Can Prevent Years of Chronic Headaches, Confusion and Memory Loss 2) Radiosurgery Proven Safe, Effective Treatment for Trigeminal Neuralgia
Media representatives are invited to attend the AAN Annual Meeting April 12-19 in Boston. Following are some of the studies that will be presented: 1) Smoking Increases Risk of Dementia 2) Estrogen Replacement Therapy Tied to Reduced Risk of Alzheimer's Disease 3) Pallidotomy Improves Verbal Memory for Parkinson's Patients
Cladribine, a chemotherapy drug, drastically lowered counts of a kind of white blood cell (known as a lymphocyte) in patients with chronic progressive multiple sclerosis, according to a study presented during the American Academy of Neurology's 49th Annual Meeting April 12-19 in Boston. EMBARGOED FOR RELEASE UNTIL 7:30 AM, WEDNESDAY, APRIL 16, 1997
Individuals who sleep more than eight hours a night or take daytime naps are 50 percent more likely to suffer a stroke or develop heart disease, according to a study published in the April issue of the American Academy of Neurology's scientific journal, Neurology.
Medical professionals and patients are not being informed or warned about the serious dangers associated with a migraine drug, according to an article published in the May issue of the American Academy of Neurology's scientific journal, Neurology.
Researchers have discovered a new eating disorder in which some patients with right anterior brain lesions suddenly become compulsively addicted to thinking about and eating fine foods. Called Gourmand syndrome, the new disorder is presented in the May issue of the American Academy of Neurology's scientific journal, Neurology.
Women who use estrogen replacement therapy are less likely to develop Alzheimer's disease, according to a study published in the June issue of the American Academy of Neurology's scientific journal, Neurology.
Existing research shows no link between silicone breast implants and neurological disorders, according to a special article published by the American Academy of Neurology's Practice Committee in the June issue of the Academy's scientific journal, Neurology.
The drug pramipexole improves symptoms for advanced ParkinsonÃÂs disease patients, according to a study published in the July issue of the American Academy of NeurologyÃÂs scientific journal, Neurology.
AlzheimerÃÂs disease patients who take part in clinical trials are 50 percent less likely to be placed in a nursing home, according to a study published in the July issue of the American Academy of NeurologyÃÂs scientific journal, Neurology.
The American Academy of Neurology has issued guidelines for neurologists on the ethical considerations that arise in the managed care environment. The guidelines are published in the August issue of the AAN's scientfic journal, Neurology. EMBARGOED UNTIL AUGUST 20, 1997.
Headaches that begin during exercise and go away with rest may be a sign of heart disease, according to a report in the September issue of Neurology, the scientific journal of the American Academy of Neurology. Embargoed For Release Until Monday, September 22, 1997.
Shakespeare vividly described sleep disorders affecting his characters centuries before the public and medical professionals recognized these common, often treatable problems, according to a Los Angeles neurologist and sleep disorder specialist.
People suffering with migraine headaches may now find quick relief - as fast as 15 minutes - with a simple-to-use nasal spray of the drug sumatriptan, an effective migraine treatment also prescribed in oral or injection form. EMBAROGED FOR RELEASE UNTIL NOVEMBER 21, 1997
Two recent studies show that the drug zolmitriptan (brand name Zomig) begins to relieve severe or moderate migraine headache in as little as 30 minutes. EMBARGOED FOR RELEASE UNTIL NOVEMBER 21, 1997
Women may be able to reduce memory loss and boost thinking power with estrogen replacement therapy (ERT), according to a study published in the December issue of Neurology, the American Academy of Neurology's scientific journal. Embargoed for Release until Monday, December 22, 1997.
A new, longer-acting treatment for migraine, naratriptan, quickly relieves pain and disability associated with migraine and greatly reduces headache recurrence, according to a study published in the December issue of Neurology, the American Academy of Neurology's scientific journal. Embargoed for Release until Monday, December 22, 1997.
A major public service campaign for television is being launched January 8, 1998, to raise awareness of the signs and symptoms of stroke, or "brain attack." For Immediate Release.
Alzheimer's disease(AD)patients suffering with memory and other cognitive impairments may find help with donepezil. The currently-available drug improves patients' cognition and ability to function, according to a study published in the January issue of Neurology, the American Academy of Neurology's scientific journal. EMBARGOED FOR RELEASE UNTIL JANUARY 22, 1998.
Ethnic and cultural origin appear to play a key role in who will develop Parkinson's disease (PD) and why, according to a study published in the January issue of Neurology, the American Academy of Neurology's scientific journal. EMBARGOED FOR RELEASE UNTIL JANUARY 22, 1998.
The precise location in the brain that produces the sounds of tinnitus, a ringing in the ears that affects millions of people, has been identified. This marks a major step toward hope for an effective treatment. Tinnitus patients also had abnormal links between their hearing systems and their brains' emotion control centers, as well as other brain transformations, according to a study published in the January issue of Neurology, the American Academy of Neurology's scientific journal. EMBARGOED FOR RELEASE UNTIL JANUARY 22, 1998.
The multiple sclerosis drug glatiramer acetate (previously called copolymer 1) sustains its effect for patients for at least two-and-a-half years, according to a study published in the March issue of Neurology, the American Academy of Neurology's scientific journal.
A new study helps determine the risk of developing multiple sclerosis for siblings of MS patients. The study is published in the March issue of Neurology, the scientific journal of the American Academy of Neurology
By treating children's sleep disorders, parents may find that their attention deficit hyperactivity disorder (ADHD) improves as well, according to a new study.
A new test can help scuba divers determine their risk of developing brain injury from diving.
Women in the early stages of Parkinson's disease may find some relief with estrogen replacement therapy.
Regular exercise may reduce the risk of developing Alzheimer's disease, according to a new study.
A rare form of dementia brings out artistic talents in people who never had them before, according to a study released during the American Academy of Neurology's 50th Anniversary Annual Meeting.
Use of the first treatment for acute stroke is effective in a community setting, according to a study released during the American Academy of Neurology's 50th Anniversary Annual Meeting April 25-May 2 in Minneapolis, MN.
For some people, suffering a severe stroke would be worse than dying, according to a survey of 1,261 people at high risk for stroke.
A new study shows how the brain works to repair and reorganize itself to recover lost speech capabilities after a stroke.
Epilepsy patients with an implanted device that electrically stimulates the left vagus nerve in the neck continue to have fewer seizures after three years with few side effects, according to a new study.
New treatments for Alzheimer's disease may help patients perform their daily activities and relieve stress for their caregivers, according to several studies on two new drugs.
Use of surgical implants providing electrical stimulation to the brain reduces tremor and other symptoms in Parkinson's disease and essential tremor patients, according to several studies presented at the American Academy of Neurology's 50th Anniversary Annual Meeting.
Elderly smokers may lose their cognitive abilities, such as remembering, thinking or perceiving, more rapidly than elderly nonsmokers.
Stroke patients treated with the new stroke drug tissue plasminogen activator (t-PA) generally have better outcomes and therefore are less costly to the health care system than those not treated, according to an article published in the April issue of Neurology, the scientific journal of the American Academy of Neurology.
Using estrogen could reduce the risk of dementia for women with Parkinson's disease, according to a new study.
The generic drug amantadine can improve motor fluctuations and dyskinesias (jerky or fragmented involuntary muscle movements) that occur after long-term use of Parkinson's medications, according to a study published in the May issue of Neurology, the scientific journal of the American Academy of Neurology.
A gene therapy technique may provide a new treatment for fatal, cancerous brain tumors, according to a study published in the May issue of Neurology, the scientific journal of the American Academy of Neurology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right